Expression and modulation of Na+/H+ exchanger 1 gene in hepatocellular carcinoma: A potential therapeutic target

Journal of Gastroenterology and Hepatology (Australia)

Volumn 26, Issue 2, 2011, Pages 364-370

  Yang, Xuekang ^a   Wang, Desheng ^a   Dong, Wei ^a   Song, Zhenshun ^a   Dou, Kefeng ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Gene expression; Hepatocellular carcinoma; Tumor cell growth

Indexed keywords

5 (N ETHYL N ISOPROPYL)AMILORIDE; SMALL INTERFERING RNA; SODIUM PROTON EXCHANGE PROTEIN 1;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; COLORIMETRY; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE SPECTROSCOPY; GENE EXPRESSION; GENETIC TRANSFECTION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 78851469003     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2010.06382.x     Document Type: Article

References (38)

1. Poon RT, Fan ST, Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann. Surg. 2000; 232: 10-24.
2. Zhang HK, Pan K, Wang H etal. Decreased expression of ING2 gene and its clinicopathological significance in hepatocellular carcinoma. Cancer Lett. 2008; 261: 183-92.
3. Capocaccia R, Sant M, Berrino F etal. Hepatocellular carcinoma: trends of incidence and survival in Europe and the United States at the end of the 20th century. Am. J. Gastroenterol. 2007; 102: 1661-70.
4. El-Serag HB. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 2004; 127: 27-34.
5. Thomas MB, Zhu AX. Hepatocellular carcinoma: the need for progress. J. Clin. Oncol. 2005; 23: 2892-9.
6. Akriviadis EA, Llovet JM, Efremidis SC etal. Hepatocellular carcinoma. Br. J. Surg. 1998; 85: 1319-31.
7. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: global burden of disease study. Lancet 1997; 349: 1269-76.
8. Schafer DF, Sorrell MF. Hepatocellular carcinoma. Lancet 1999; 353: 1253-6.
9. Makuuchi M, Takayama T, Kubota K etal. Hepatic resection for hepatocellular carcinoma: Japanese experience. Hepat. Gastroenterol. 1998; 45: 1267-74.
10. Fan ST, Lo CM, Liu CL etal. Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann. Surg. 1999; 229: 322-30.
11. Thorgeirsson SS, Grisham JW. Molecular pathogenesis of human hepatocellular carcinoma. Nat. Genet. 2002; 31: 339-46.
12. Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 2002; 35: 519-24.
13. Pang R, Tse E, Poon RT. Molecular pathways in hepatocellular carcinoma. Cancer Lett. 2006; 240: 157-69.
14. Qian C, Drozdzik M, Caselmann WH, Prieto J. The potential of gene therapy in the treatment of hepatocellular carcinoma. J. Hepatol. 2000; 32: 344-51.
15. Ruiz J, Qian C, Drozdzik M, Prieto J. Gene therapy of viral hepatitis and hepatocellular carcinoma. J. Viral. Hepat. 1999; 6: 17-34.
16. Lang F, Ritter M, Gamper N etal. Cell Volume in the regulation of cell proliferation and apoptotic cell death. Cell. Physiol. Biochem. 2000; 10: 417-28.
17. + exchanger. Blood 2000; 95: 1427-34.
18. + exchanger 1 (NHE 1) antisense expression vector on NHE1 gene expression in human lung adenocarcinoma cells and its biological significance. Chin. J. Tuberc. Resp. Dis. 2004; 27: 191-94.
19. + exchanger isoform-1 and the extracellular signal-regulated kinase induces apoptosis: a time course of events. Cell. Physiol. Biochem. 2006; 18: 211-22.
20. Gillies RJ, Raghunand N, Karczmar GS, Bhujwalla ZM. MRI of the tumor microenvironment. J. Magn. Reson. Imaging 2002; 16: 430-50.
21. Perez-Sala D, Colores-Escobar D, Mollinedo F. Intracellular alkalinization suppresses lovastatin-induced apoptosis in HL-60 cells through the inactivation of a pH-dependent endonuclease. J. Biol. Chem. 1995; 270: 6235-42.
22. + exchanger isoforms. Am. J. Physiol. 1995; 268: 283-96.
23. + exchangers of mammalian cells. J. Biol. Chem. 1997; 272: 22373-6.
24. + exchangers. J. Biol. Chem. 2000; 275: 1-4.
25. Mclean LA, Roscoe J, Jorgensen NK etal. Malignant gliomas display altered pH regulation by NHE1 compared with nontransformed astrocytes. Am. J. Physiol. Cell. Physiol. 2000; 278: 676-88.
26. + exchanger. Leukemia Res. 2007; 31: 507-14.
27. + exchange and growth factor induced cytosolic pH changes, Role in cellular proliferation. Biochim. Biophys. Acta 1989; 988: 73-97.
28. Lagadic-Gossmann D, Huc L, Lecureur V. Alterations of intracellular pH homeostasis in apoptosis: origins and roles. Cell Death Differ. 2004; 11: 953-61.
29. Pirkebner D, Fuetsch M, Wittmann W etal. Reduction of intracellular pH inhibits constitutive expression of cyclooxygenase-2 in human cancer cells. J. Cell Chem. 2004; 198: 295-301.
30. +-mediated unifying approach: pH-related and pH-unrelated mechanisms. Crit. Rev. Oncog. 1995; 6: 1-33.
31. + exchanger-dependent intracellular alkalinization is an early event in malignant transformation and plays an essential role in the development of subsequent transformation-associated phenotypes. FASEB J. 2000; 14: 2185-97.
32. Boyer MJ, Tannock IF. Regulation of intracellular pH in tumor cell lines: influence of microenvironmental conditions. Cancer Res. 1992; 52: 4441-7.
33. Stubbs M, Veech RL, Griffiths JR. Tumor metabolism: the lessons of magnetic resonance spectroscopy. Adv. Enzyme. Regul. 1995; 35: 101-15.
34. + Exchanger (NHE1) creates acidic microenvironments leading to Hyaluronidase-2 and Cathepsin B activation and breast tumor cell invasion. J. Biol. Chem. 2004; 279: 26991-7007.
35. Liu HF, Teng XC, Zheng JC etal. Effect of NHE1 antisense gene transfection on the biological behavior of SGC-7901 human gastric carcinoma cells. World J. Gastroenterol. 2008; 14: 2162-7.
36. Sgambato A, Cittadini A, Faraglia B etal. Multiple functions of p27 (Kip1) and its alterations in tumor cells: a review. J. Cell Physiol. 2000; 183: 18-27.
37. Kothapalli D, Zhao L, Hawthore EA etal. Hyaluronan and CD44 antagonize mitogen-dependent cyclin D1 expression in mesenchymal cells. J. Cell Biol. 2007; 176: 535-44.
38. Lloyd RV, Erickson LA, Jin L etal. p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am. J. Pathol. 1999; 154: 313-23.